Web Watch

Share this article:
Internet advertising revenues reached a new high of $4.9 million in the first quarter of 2007. “The continued growth of online ad revenues clearly illustrates marketers' increased comfort with the extraordinary vitality and accountability of this medium,” said Internet Advertising Bureau president & CEO Randall Rothenberg. Despite a generally flat advertising environment in 2007, Internet advertising was up 26% over first quarter 2006 levels.

This shift of media expenditures is likely to continue and even accelerate in the years to come. And, there's a good argument that the Internet isn't really getting anywhere near the advertising investment it deserves right now.  An online study by IBM confirms that ad dollars are still very late in aligning with the amount of time consumers now spend online.

The IBM study was conducted in mid-April through mid-June and surveyed people in the US, UK, Germany, Australia and Japan. The global findings suggest Internet usage is now on par with TV usage. Nineteen percent of the respondents said they spend six hours a day on the Internet compared to 9% of respondents that spend this much time watching TV; 66% reported watching one to four hours of TV per day versus 60% that spend this amount of time on the Internet. As more people shift their media time from TV to the Internet, the dollars will eventually follow, even if there is a wide disparity today.

IBM analysts believe the role of advertising agencies will change as well. Agencies will need to provide their customers with a better understanding of how to use the Internet as a marketing vehicle and develop creative that will either be more compelling or be ignored.

The IBM study highlights can be found at www-03.ibm.com/press/us/en/pressrelease/22206.wss.

Dan McKillen is president of the HealthDay news service

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...